Advertisement

Topics

Latest "Finish Line" News Stories

21:15 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "Finish Line" found in our extensive news archives from over 250 global news sources.

More Information about Finish Line on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Finish Line for you to read. Along with our medical data and news we also list Finish Line Clinical Trials, which are updated daily. BioPortfolio also has a large database of Finish Line Companies for you to search.

Showing "Finish Line" News Articles 1–25 of 3,900+

Relevant

Changing the finish line: Syneos talks bringing payer, patient voice into drug development

The drug development âfinish lineâ is not regulatory approval, says Syenos Health chief scientific officer Judith Ng-Cashin, MD, who discusses bringing the payer and patient voice into the process.


ADMA Biologics: Finish Line Ahead?

Intercept And NASH: Itching To The Finish Line


Islet encapsulation therapy — racing towards the finish line?

BMS first to cross finish line in China PD-1 approval race

Aimmune and DBV Eye the Finish Line for Peanut Allergy Treatments http://dlvr.it/Qlgk4c pic.twitter.com/2TZ1d85mtZ

Aimmune and DBV Eye the Finish Line for Peanut Allergy Treatments http://dlvr.it/Qlgk4c  pic.twitter.com/2TZ1d85mtZ

Boehringer increases manufacturing capacity in China

By adding a new fill-and-finish line at its Shanghai site, the German drugmaker aims to be a "one-stop shop" for GMP contract manufacturing.

Read our previous coverage of how the laureates’ discoveries have impacted medicine: #Opdivo, the first PD-1 inhibitor, breezes across the finish line https://rdcu.be/8f4h ; investors pursue immuno-oncology startups https://rdcu.be/8f2Y 

Read our previous coverage of how the laureates’ discoveries have impacted medicine: #Opdivo, the first PD-1 inhibitor, breezes across the finish line https://rdcu.be/8f4h ; investors pursue immuno-oncology startups https://rdcu.be/8f2Y 

STAT Plus: Pfizer, Novartis pair up on fatty liver drug trials as rivals near finish line

Two pharma giants are pairing up on the belief that attacking NASH with two or more drugs that act in the liver differently will ultimately bring the most benefit to…

New Drugs Approved In May

The bench to bedside journey of drugs is no easy task. Some drug candidates fail to complete the journey while many make it to the finish line only after undergoing numerous obstacles.

CMO Rentschler signs Ultragenyx fill/finish deal for US supply

Ultragenyx Pharmaceutical is transferring fill/finish activities for Mepsevvi from Rentschler Biopharmaâs facility in Germany, to Rentschler Fill Solutions in Austria.

Vical Faced With Failure of Another Vaccine Trial

Company will focus on getting oral anti-fungal candidate VL-2397 over the finish line, after another pipeline blow-up.   

Rentschler opens GMP fill/finish facility in Austria

Aseptic fill/finish contractor Rentschler Fill Solutions inaugurated the new facility in Austriaâs eastern town of Rankweil.

Aimmune and DBV Eye the Finish Line for Peanut Allergy Treatments

An estimated 15 million people in the United States have allergies to more than 170 different foods, according to the non-profit Food Allergy Research and Education. New health data suggests the frequency of food allergies in children under 18 has risen 70 percent since 1997, CNBC reported.

Mylan Sees Generic Advair Marathon Nearing FDA Finish Line

Company management expressed confidence its application for the first generic Advair is approvable, although the US agency didn’t clear it...   

Symbiosis gets FDA approval for manufacturing fill/finish process

Symbiosis recently hosted a successful inspection by the FDA for the aseptic manufacture of viral vector products for commercial supply into the U.S market at its GMP manufacturing The post Symbiosis gets FDA approval for manufacturing fill/finish process appeared first on Pharma Business review.

Eerste vrijgave Michter's US*1 Toasted Barrel Finish Bourbon in drie jaar

LOUISVILLE, Kentucky, 22 augustus 2018 /PRNewswire/ -- Michter's Distillery, gevestigd in Louisville, Kentucky, zorgt voor de eerste vrijgave van haar innovatieve US*1 Toasted Barrel Finish Read more...

Passage of Sports Medicine Clarity Act Improves Care for All Athletes

ROSEMONT, Ill. (PRWEB) October 05, 2018 The American Orthopaedic Society for Sports Medicine ( AOSSM ) is proud to have been part of the process to cross the finish line with the passage of the Sports Medicine Licensure Clarity Act (H.R.302) which was signed into law this week as part of the...

Regeneron's Less Frequent Eylea Dosing Makes Late Sprint Across FDA Finish Line

Regeneron's blockbuster AMD biologic Eylea improved its ability to compete with future longer-acting VEGF inhibitors with a label supporting every...   

Mardi Gras Selected As Name For Largest Carnival Cruise Line Ship Ever Constructed

MIAMI, Dec. 5, 2018 /PRNewswire/ -- In a nod to Carnival Cruise Line's rich history as America's Cruise Line, the line announced today that it Read more...

Being nice tied to financial hardship, study finds – UPI.com

UPI.comBeing nice tied to financial hardship, study findsUPI.comTHURSDAY, Oct. 11, 2018 -- When it comes to money, nice people really are more likely to finish last, a new study suggests. Researchers analyzed data from more than 3 million people and found that those who were nice were at increased risk for ...Nice kids come last - new study finds agreeable personalities have less moneyTelegraph.co...

Akebia Merges With Keryx As Anemia Drug Race Nears Finish Line

The race to treat anemia with a pill, not an injectable biologic, just took a new turn. Akebia Therapeutics (NASDAQ: AKBA), which is battling with FibroGen (NASDAQ: FGEN) to bring an anemia pill to market, has just announced plans to merge with kidney drug disease developer Keryx Pharmaceuticals (NASDAQ: KERX) in an all-stock deal that […]

Will These Alzheimer's Drugs In Phase 3 Clinical Trials Cross The Finish Line?

The development of Alzheimer's drugs has been marred by a high failure rate. Despite the high failure rate, the pharma companies have not shied away from making investments in Alzheimer's research. Let's take a look at the companies whose Alzheimer's drugs are in phase III development.

RNase H2, mutated in Aicardi-Goutieres syndrome, promotes LINE-1 retrotransposition

Long INterspersed Element class 1 (LINE-1) elements are a type of abundant retrotransposons active in mammalian genomes. An average human genome contains ~100 retrotransposition-competent LINE-1s, whose activity is influenced by the combined action of cellular repressors and activators. TREX1, SAMHD1 and ADAR1 are known LINE-1 repressors and when mutated cause the autoinflammatory disorder Aicardi...

Antibiotics: Stay the Course?

Researchers debate whether we should finish our antibiotic prescription.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks